S&P Futures
4,051.75 -32.50 (-0.80%) Dow Futures
33,888.00 -158.00 (-0.46%) Nasdaq Futures
12,084.50 -137.75 (-1.13%) Russell 2000 Futures
1,901.90 -17.60 (-0.92%) Crude Oil
78.05 -1.63 (-2.05%) Gold
1,945.70 +0.10 (+0.01%)
G Medical Innovations Holdings Ltd (GMVD)
Pre-Market:
Chart Events
Performance Outlook
| Previous Close | 2.9900 |
| Open | 2.9500 |
| Bid | 0.0000 x 2200 |
| Ask | 0.0000 x 900 |
| Day's Range | 2.8300 - 3.0395 |
| 52 Week Range | 1.9400 - 192.5000 |
| Volume | |
| Avg. Volume | 398,365 |
| Market Cap | 4.276M |
| Beta (5Y Monthly) | -1.13 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.3000 |
| Earnings Date | Nov 18, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for GMVD
Related Research
- G Medical Innovations HoldingsDaily – Vickers Top Buyers & Sellers for 01/12/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moat18 days agoArgus Research
- GlobeNewswire
G Medical Innovations announces receiving notice of patent issuance from the USPTO for vital signs sensors
Rehovot, Israel, Jan. 30, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company” or “G Medical Innovations”) today announced that it has received a patent issue notification from the United States Patent and Trademark Office (“USPTO”) for its monitoring products marketed in the United States. The patent, expected to be issued on February 7, 2023, Method and System for Vital Signs Monitoring with Earpiece, covers the vital signs monitoring system that the Compa
- GlobeNewswire
G Medical Innovations to announce receiving of 2 (two) granted patents from the USPTO for its Prizma care and other physiological sensors developed by the company.
Irvine, California, Dec. 05, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the “Company” or “G Medical Innovations”) today announced that it received 2 (Two) granted patents from the United States Patent and Trademark office for its monitoring products marketed in the U.S. market. The granted patents are: METHOD, DEVICE AND SYSTEM FOR NON-INVESIVELY MONITORING PHYSIOLOGICAL PARAMETERS This patent integrates sensing mechanism that allows the monitoring system to ana
- GlobeNewswire
G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) Announces Receipt of Notice of Deficiency with Nasdaq Continued Listing Requirements
Irvine, California, Nov. 22, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”), a telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, medical professionals, and healthcare institutions, has received today a written notice (the “Notice”) from Nasdaq Stock Market LLC, indicating that the Company is no longer in compliance with the minimum shareholders’ equity requirement for continued listing
